Technologies
Counseling & Strategic Advice
IP Transactions
Litigation
PTAB Proceedings
Start-Up
Technology Transfer
Trademark & Designs
U.S. Patent Procurement (Application Drafting & Prosecution)Fast Facts
Law Firm
Headquartered within steps of the USPTO with an affiliate office in Tokyo, Oblon is one of the largest law firms in the United States focused exclusively on intellectual property law.
History
1968
Norman Oblon with Stanley Fisher and Marvin Spivak launched what was to become Oblon, McClelland, Maier & Neustadt, LLP, one of the nation's leading full-service intellectual property law firms.
Global Reach
Outside the US, we service companies based in Japan, France, Germany, Italy, Saudi Arabia, and farther corners of the world. Our culturally aware attorneys speak many languages, including Japanese, French, German, Mandarin, Korean, Russian, Arabic, Farsi, Chinese.
ACCOLADES
Oblon's professionals provide industry-leading IP legal services to many of the world's most admired innovators and brands.
Career
From the minute you walk through our doors, you'll become a valuable part of a team that fosters a culture of innovation, client service and collegiality.
GET In Touch
Patent Forms
The United States Patent and Trademark Office (USPTO) issued final rules implementing the inventor's oath or declaration provisions of the America Invents Act (AIA) on August 14, 2012.
Our Blogs
LATEST NEWS
PUBLICATIONS
Les Nouvelles - Licensing Executives Society International (LESI)
Events
November 11, 2024
October 9-10, 2024 in Tokyo and Osaka
October 1 and 3, 2024
Blogs
Updated News
Adjusted USPTO Patent Fees Effective October 2020
The USPTO has recently reported fee increases to take effect on October 2, 2020 relating to the filing and prosecution of patent applications and the maintenance of patents.
Ajinomoto Delaware Litigation Heads Toward Victory with Patent Owner's Asserted Claims Found Indefinite In Claim Construction Ruling
Recently Judge Mitchell S. Goldberg for the U.S. District Court for the District of Delaware approved and adopted Magistrate Judge Lloret's Markman decision in its entirety, finding Plaintiff Kyowa Hakko Bio Co.'s (KHB) asserted patent claims invalid as indefinite. KHB had asserted infringement of its U.S. Patent RE45,723 allegedly covering an Ajinomoto process for manufacturing glutamic acid commonly used as an additive in food products.
